|Mr. Michael Ryan Gorenstein||Chairman, Pres & CEO||266.93k||N/A||1987|
|Ms. Xiuming Shum||Exec. VP of Legal and Regulatory Affairs & Corp. Secetary||175k||N/A||N/A|
|Mr. Jerry Filomena Barbato||Chief Financial Officer||N/A||N/A||N/A|
|Ms. Anna Shlimak||Head of Investor Relations & Communications||N/A||N/A||N/A|
|Mr. Eric Klein||Head of Marketing||N/A||N/A||N/A|
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations (MMPR). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in in Toronto, Canada.
Cronos Group Inc.’s ISS Governance QualityScore as of October 4, 2019 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 7; Compensation: 9.